Pharmaxis Ltd.

Pharmaxis Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.03
Market Cap
AUD96.61 M
Shares Outstanding
394.32 M
Public Float
320.43 M

Profile

Address
20 Rodborough Road
Sydney New South Wales (NSW) 2086
Australia
Employees -
Website http://www.pharmaxis.com.au
Updated 07/08/2019
Pharmaxis Ltd. operates as a specialty pharmaceutical company, which engages in the development and commercialization of therapeutic products for chronic respiratory disorders, autoimmune diseases, and improved lung function test. It operates through the following segments: Bronchitol and Aridol Business and New Drug Development. The Bronchitol and Aridol Business segment covers the ongoing clinical development, manufacture, and sale of the Bronchitol and Aridol globally.

Financials

View All
Created with Highcharts 5.0.14Pharmaxis Ltd.Net Income. Fiscal year is July-June. All values AUD Thousands.51 81851 81818 46618 46616 46316 46318 34618 3466 4286 42820142015201620172018010k20k30k40k50k60k
Created with Highcharts 5.0.14Pharmaxis Ltd.Sales/Revenue. Fiscal year is July-June. All values AUD Thousands.5 0365 03657 74157 74114 33514 33513 77513 77549 41249 41220142015201620172018010k20k30k40k50k60k70k

Kathleen M. Metters
Non-Executive Director
Kathleen M. Metters
Non-Executive Director